CABOT CORP (CBT)
Materials · specialty chemicals · NYSE
Cabot is a leader in specialty chemicals, providing critical carbon-based materials that enhance the performance of tires, energy storage, and industrial applications globally.
What CABOT CORP does
Cabot Corporation is a global specialty chemicals and performance materials company. It primarily produces carbon black, specialty carbons, and performance composites used in a wide range of industrial and consumer applications, including tires, batteries, and performance additives.
Themes: automotive supply chain, tire performance materials, energy storage / battery materials, performance additives
Fundamentals
- Price$85.19 as of 2026-08-21 close
- Market cap$4.4B as of 2026-08-21
- 1-year return+7.7% 2025-08-21 close $79.10 → 2026-08-21 close $85.19
- P/E23.51 as of 2026-08-24
- Net margin+5.2% as of 2026-08-24
- Gross margin+23.2% as of 2026-08-24
- ROE+12.1% as of 2026-08-24
- Debt / equity0.79 as of 2026-08-24
- Revenue growth (YoY)-4.7% as of 2026-08-24
- Revenue CAGR (3y)-4.9% SEC XBRL
- Beta0.85 as of 2026-08-24
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.1%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CBT compares in its sector
- price-to-earnings ratiomiddle range 94 covered Materials peers, as of 2026-08-24
- net profit marginmiddle range 142 covered Materials peers, as of 2026-08-24
- operating marginmiddle range 142 covered Materials peers, as of 2026-08-24
- gross marginmiddle range 141 covered Materials peers, as of 2026-08-24
- return on equitymiddle range 151 covered Materials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 127 covered Materials peers
- indicated dividend yieldmiddle range 95 covered Materials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 25% 124 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CBT is not currently in any published Top 10 list. Its scores are below.
Long-term score
41.1 #796 of 987 scored · #48 of 66 in Materials
Capital return 71st (consecutive years of dividend increases 5 years) and valuation 54th (price to earnings 23.5, price to book 2.6); weakest is growth (9th, revenue growth year over year -4.7%, 3-year revenue CAGR -4.9%).
Short-term score
41.8 #1311 of 1,704 scored · #64 of 83 in Materials
Setup 52nd: no Elliott-wave labelling currently fits its swings; catalysts 47th: open-market insider buys in 90 days 9, the analyst consensus rating is unchanged since the prior reading; weakest is volume and participation 33rd: it gapped 4.9% below the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CBT's dividend was covered by reported results (earnings payout 29%, free-cash-flow payout 25%). This describes past coverage, not a forecast.
- Earnings payout29% dividends / net income
- Free-cash-flow payout25% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How CABOT CORP looks technically
CABOT CORP (CBT) is trading 11.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 109 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 45, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 14 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 11.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +11.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $87.98 | $87.98 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $76.19 | $76.19 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 10 calendar days ago — the swings before that are what the structure reading is measured on | 10 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 89.23. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 109 trading days ago — a "golden cross", a bullish long-term signal | 109 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend) | 17.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 45, neither overbought (above 70) nor oversold (below 30) | 45.3 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($78.58 to $89.23) — its "stochastic" reading is 62 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 62.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 17 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $94.53 | $94.53 |
|---|---|---|
| From the 52-week high | it is 9.9% below its 52-week high (its highest price of the past year) | -9.9% |
| Above the 52-week low | it is 46.0% above its 52-week low (its lowest price of the past year) | +46.0% |
| Below the 52-week high | it is 9.9% below its highest point of the past year | 9.9% |
| Since a 20-day breakout | it made a new 20-day low about 14 trading days ago | 14 sessions |
| Since a 55-day breakout | it made a new 55-day high about 40 trading days ago | 40 sessions |
| All-time high | its highest closing price on record is $117.46 (set on 2024-11-07) | $117.46 |
| Given back of the 52-week move | over the past year its closes ranged ($58.71 to $93.40), and it has given back roughly a quarter of its rise from last year’s low — 24% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $70.85 to $71.96. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 23.7% |
| From the all-time high | it is 27.5% below its all-time high | -27.5% |
| Nearest price level | it is trading 0.6% above a support level at $84.67 — a price it turned at three times since 2025-01-10, most recently on 2025-04-02. Since 2024-08-21 it has 11 such levels below the current price and 7 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.6% |
| All-time low | its lowest closing price on record is $7.97 (set on 2009-03-06) | $7.97 |
| Above the all-time low | it is 968.9% above its all-time low | +968.9% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 71% of it) | 29th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.67 between its high and its low — about 3.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.67 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $82.39 and $91.54 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $82.39 – $86.96 – $91.54 |
| Typical daily range (% of price) | its price moves about 3.1% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.1% |
| Stretch from the 200-day average | it is trading 3.4 daily ranges above its 200-day average price (11.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.84× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 8 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 8 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.6% |
|---|---|---|
| Open gap | it gapped 4.9% below the previous close 16 sessions ago and has not traded back through the level it left behind at 91.53 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -4.9% |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 6.5 percentage points (the stock lost 4.1% while the market gained 2.3%) | -6.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 5.6 percentage points (the stock gained 8.7% while the market gained 3.1%) | +5.7% |
| vs market, 6 months | over the past 6 months this stock beat the market by 1.6 percentage points (the stock gained 12.7% while the market gained 11.1%) | +1.6% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 12.8 percentage points (the stock gained 7.7% while the market gained 20.5%) | -12.8% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 2.9% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 6% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $80.71 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +5.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is sitting right on the average price paid since it last reported on 2026-08-03 (its 8-K), so the typical buyer over that stretch is roughly break-even. That average is $85.52 — a volume-weighted average of daily closes over 15 sessions, not a true tick-by-tick VWAP. | -0.4% |
Price levels it has turned at before
CBT last closed at $85.19 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 7 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $84.67 | Support | 0.6% below the last close | turned there three times · 2025-01-10 to 2025-04-02 |
| $86.77 | Resistance | 1.9% above the last close | turned there twice · 2026-05-11 to 2026-07-21 |
| $82.91 | Support | 2.7% below the last close | turned there five times · 2025-02-03 to 2025-09-05 |
| $89.19 | Resistance | 4.7% above the last close | turned there five times · 2025-02-04 to 2026-08-11 |
| $80.89 | Support | 5.0% below the last close | turned there five times · 2025-03-13 to 2026-07-08 |
| $92.70 | Resistance | 8.8% above the last close | turned there three times · 2025-01-21 to 2026-07-28 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $89.23.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $65.91 and $74.82 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $89.23.
This reading has stood for 4 trading days, since 2026-08-18.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · trendless / choppy (low ADX) · Trading inside the Ichimoku cloud · Near a support level (sitting on a price it has bounced off before) · Elliott wave 3 candidates | Learn: moving average · golden cross · adx · rsi · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.50 mean, 1=Strong Buy…5=Strong Sell) — 6 analysts
- Mean price target$91.33 range $78.00 – $100.00; median $91.00
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CBT
- Consensus EPS estimate$1.52 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Sensitivity of operating results to fluctuations in raw material costs, particularly carbon black feedstock prices.","Exposure to global economic conditions and cyclical demand in the automotive and tire industries.","Risks associated with environmental regulation and the capital-intensive nature of chemical manufacturing."]
What changed in the latest 10-Q
AI-assisted comparison of CBT's 10-Q filed 2026-05-06 against the prior one filed 2026-02-04.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-06) includes six-month ended March 31 comparisons (2026 vs 2025) in consolidated statements of operations
- Newer filing includes six-month ended March 31 comparisons in consolidated statements of comprehensive income
- Newer filing (2026-05-06) reports three-month period ended March 31, 2026 vs March 31, 2025 in all financial statements
- Newer filing includes cash flow statement for six months ended March 31, 2026 vs 2025 with acquisition activity: 'Cash paid for acquisition of business, net of cash acquired $2 ($66 million)'
- Newer filing balance sheet dated March 31, 2026 shows short-term borrowings of $175 million (compared to $14 million at September 30, 2025)
- Newer filing shows 'Proceeds from short-term borrowings (original maturities greater than 90 days)' of $15 million in six-month period
- Newer filing shows 'Proceeds from (repayments of) short-term borrowings, net (original maturities 90 days or less)' of $12 million
- Removed:
- Older filing (2026-02-04) contained three-month period ended December 31, 2025 vs 2024 in consolidated statements of operations
- Older filing contained three-month period ended December 31, 2025 vs 2024 in consolidated statements of comprehensive income
- Older filing contained balance sheet dated December 31, 2025 (replaced by March 31, 2026 in newer filing)
- Older filing contained cash flow statement for three months ended December 31, 2025 vs 2024 (replaced by six months ended March 31 in newer filing)
- Reworded:
- MD&A page number changed from 21 (older filing) to 23 (newer filing)
- Item 3 page number changed from 28 (older filing) to 29 (newer filing)
- Item 4 page number changed from 28 (older filing) to 29 (newer filing)
- Item 2 Unregistered Sales page changed from 29 (older filing) to 30 (newer filing)
- Item 5 page number changed from 29 (older filing) to 30 (newer filing)
- Item 6 page number changed from 29 (older filing) to 31 (newer filing)
- Notes:
- The two filings compare different fiscal periods: older filing covers three months ended December 31, 2025; newer filing covers three and six months ended March 31, 2026
- Financial statement line items cannot be directly compared between the two filings due to different reporting periods
- Balance sheet dates are different: December 31, 2025 (older) vs March 31, 2026 (newer)
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for CBT — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding CBT as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 10,114,535
- Reported value $761,725,693
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 3 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
CBT had 3,759,946 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
CBT had 7.28% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 10.16 days to cover at the same settlement.
- Reported short interest (shares) 3,759,946
- Short interest (% of shares outstanding) 7.28%
- Prior settlement (shares) 3,474,022
- Reported change 8.23%
- Days to cover (reported) 10.16
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Orion S.A. (OEC)
- Birla Carbon
- Tokai Carbon
- Evonik Industries (EVK.DE)
- Phillips Carbon Black
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CBT vs…
CABOT CORP is found in…
Frequently asked questions
What does CABOT CORP (CBT) do?
Cabot Corporation is a global specialty chemicals and performance materials company. It primarily produces carbon black, specialty carbons, and performance composites used in a wide range of industrial and consumer applications, including tires, batteries, and performance additives.
What sector is CABOT CORP (CBT) in?
CABOT CORP (CBT) is classified in the Materials sector. Its industry is specialty chemicals. It trades on NYSE.
Does CBT pay a dividend?
Yes — CABOT CORP (CBT) pays a dividend, with an indicated yield of about 2.06% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are CABOT CORP's (CBT) competitors?
Notable peers of CABOT CORP (CBT) include Orion S.A., Birla Carbon, Tokai Carbon, Evonik Industries and Phillips Carbon Black. This peer set is informational only — not financial advice.
Is CABOT CORP (CBT) overbought or oversold right now?
CABOT CORP (CBT) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 45, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CBT come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.